Our present study showed that COL11A1 upregulates IGFBP2 transcription by augmenting p65 DNA-binding activity in ovarian cancer cells to constitutively activate the TGF-β3 signaling pathway, thereby promoting CAF activation. Here, COL11A1 is linked to ovarian carcinoma.